Alabama SB1 regulates nonpsychoactive consumable hemp products, requiring sale only in pharmacies and classifying psychoactive derivatives of hemp as.

Alabama SB1 mandates that nonpsychoactive consumable hemp products, such as CBD-infused edibles, can only be sold in licensed pharmacies certified by the Alabama State Board of Pharmacy. It also requires these products to be tested for contaminants and to meet specific nonpsychoactive cannabinoid content. The bill classifies psychoactive derivatives of hemp, like Delta-8 THC, as Schedule I controlled substances. It repeals previous restrictions on the distribution and sale of consumable hemp products, replacing them with these new regulations.

Alabama SB1 regulates nonpsychoactive consumable hemp products, requiring sale only in pharmacies and classifying psychoactive derivatives of hemp as.

Alabama SB1 mandates that nonpsychoactive consumable hemp products, such as CBD-infused edibles, can only be sold in licensed pharmacies certified by the Alabama State Board of Pharmacy. It also requires these products to be tested for contaminants and to meet specific nonpsychoactive cannabinoid content. The bill classifies psychoactive derivatives of hemp, like Delta-8 THC, as Schedule I controlled substances. It repeals previous restrictions on the distribution and sale of consumable hemp products, replacing them with these new regulations.